You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

Lupin Launches Generic OCD Capsules in U.S., an Industrial Info Market Brief

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 87 Words
Attachment: India Pharm 0219

Indian pharmaceutical major Lupin Limited announced its launch of the antidepressant drug clomipramine hydrochloride in the U.S. market, following approval from the U.S. Food and Drug Administration

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $5.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00